Amino acid replacement: D421A.
Endogenous Rev1 in which the D421A and G422A mutations have been introduced; created via the SIRT (site-specific integrase mediated repeated targeting) technique.
Amino acid replacement: G422A.
PolZ13B, Rev1DTD has chemical sensitive phenotype
PolZ13B, Rev1DTD has increased mortality | chemical conditional phenotype